# Novo Nordisk (NVO) — Analyst Forecast

NVO · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/nvo/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 1 | 3 | 1 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | BMO Capital | Maintained | Market Perform | $40.00 |
| Sep 11, 2026 | Morgan Stanley | Downgraded | Equal-Weight → Underweight | $40.00 |
| Mar 2, 2026 | Goldman Sachs | Downgraded | Buy → Neutral | $41.00 |
| Feb 24, 2026 | JP Morgan | Downgraded | Overweight → Neutral | — |
| Jan 9, 2026 | CICC | Initiated Coverage | Outperform | $73.50 |
| Dec 8, 2025 | Argus Research | Downgraded | Buy → Hold | — |
| Nov 28, 2025 | Goldman Sachs | Maintained | Buy | $54.00 |
| Nov 25, 2025 | BMO Capital | Maintained | Market Perform | $46.00 |
| Nov 24, 2025 | HSBC | Downgraded | Buy → Hold | — |
| Oct 27, 2025 | Jefferies | Initiated Coverage | Underperform | — |
| Oct 14, 2025 | BMO Capital | Maintained | Market Perform | $55.00 |
| Oct 2, 2025 | HSBC | Upgraded | Hold → Buy | $70.00 |
| Sep 29, 2025 | Morgan Stanley | Downgraded | Equal-Weight → Underweight | $47.00 |
| Sep 17, 2025 | Berenberg | Upgraded | Hold → Buy | — |
| Aug 19, 2025 | TD Cowen | Maintained | Buy | $70.00 |
| Aug 5, 2025 | UBS | Downgraded | Buy → Neutral | — |
| Jul 31, 2025 | HSBC | Downgraded | Buy → Hold | — |
| Jul 30, 2025 | Barclays | Downgraded | Overweight → Equal-Weight | — |
| Apr 17, 2025 | BMO Capital | Downgraded | Outperform → Market Perform | $64.00 |
| Jan 8, 2025 | UBS | Upgraded | Sell → Buy | — |

## Frequently Asked Questions

### Is NVO a buy, sell, or hold?

Analysts covering Novo Nordisk currently average a Hold rating: 1 buy, 3 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on NVO?

On Oct 12, 2026, BMO Capital maintained Novo Nordisk at Market Perform with a price target of $40.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).